KRAS mutation initiates the tumour process as pancreatic intraepithelial neoplasia (panIN) with a relatively long latency or other tumour-suppressing gene mutations, and panIN progresses to pancreatic cancer [34]. The gene discussed is KRAS; the disease is pancreatic neoplasm.